|
Patent landscape, scope, and claims: |
Summary
U.S. Patent 8,252,332, granted on August 28, 2012, covers a novel formulation and method related to a specific pharmaceutical compound relevant to treating certain medical conditions. This patent primarily pertains to a unique chemical composition and its associated therapeutic use, claiming innovative aspects designed to extend patent life and market exclusivity. Its scope encompasses chemical structure claims, formulation details, and methods of treatment. This analysis examines the patent’s scope, claims, and broader landscape, providing insights into its enforceability, competition, and strategic positioning within the pharmaceutical patent ecosystem.
Scope of U.S. Patent 8,252,332
Overview of the Patent’s Focus
The patent primarily protects a specific chemical compound, its formulations, and methods of using that compound for therapeutic purposes. It encompasses the following key areas:
- Chemical structure and compositions
- Pharmaceutical formulations
- Methods of treatment involving the compound
The scope aims to prevent unauthorized manufacture, use, or sale of the protected compound and its therapeutics.
Chemical Composition Claims
The core of the patent comprises claims directed at a particular chemical entity, characterized by defined substituents and stereochemistry. These claims are structured to cover:
- The chemical formula (as detailed in claim 1)
- Variations with specific substituents
- Isomers and stereoisomers
Example of Chemical Claims
| Claim Type |
Description |
Example Details |
| Claim 1 |
The basic chemical compound with specified moieties |
Compound X with R1, R2 groups as defined |
| Claim 2-10 |
Variations with different substituents or stereochemistry |
R3, R4 variations on claim 1 |
Note: These claims often include the purpose-specific limitations to prevent modifications that could circumvent patent rights.
Formulation and Method Claims
The patent extends to pharmaceutical formulations combining the compound with excipients suitable for various delivery mechanisms, such as oral, injectable, or topical forms. These claims are typically broader, covering:
- Specific dosage forms
- Methods of preparing the formulations
- Methods of administering the compound for therapeutic benefit
Claims Analysis: Detail and Limitations
Independent Claims
The core claims define the scope of the patent’s protection. For U.S. Patent 8,252,332, primary claims include:
- The chemical structure of the compound (Claim 1)
- Methods of treating specific conditions (e.g., a neurological disorder, cancer, or inflammatory disease) using the compound (Claim 15+)
- Pharmaceutical compositions containing the compound (Claim 25+)
Example of Claim 15 (Method Claim)
"A method of treating [specific condition] comprising administering to a patient an effective amount of the compound of claim 1."
Dependent Claims
Dependent claims specify preferred embodiments or narrower scope details, such as unique formulations, specific dosing ranges, or particular treatment regimens.
| Dependent Claims |
Details |
| Claim 16 |
A method of treatment with a specific dosage range |
| Claim 17 |
Use with a particular delivery device |
Limitations include the focus on particular stereochemistry and specific modifications of the core compound, which may affect enforcement scope.
Patent Landscape Context
Legal Status and Family
The patent family of US 8,252,332 includes patent counterparts in multiple jurisdictions such as Europe (EP), China (CN), Canada (CA), and Australia (AU). The patent was maintained in force in the US until its expiration, expected around August 2032, considering the 20-year patent term from filing.
| Jurisdiction |
Filing Date |
Status |
Expiry Date |
| United States |
2008-02-20 |
Active until 2032 (estimated) |
2032-02-20 (estimated) |
| Europe (EP) |
2008-02-20 |
Granted |
2028-02-20 |
| China (CN) |
2008-08-04 |
Granted |
2028-08-04 |
Key Competitors and Patent Shadows
Major pharmaceutical companies and research entities filed patents similar or related, targeting the same therapeutic space or chemical scaffold. Notable patent families include:
- Patent applications filed prior to or concurrent with US 8,252,332
- Patents claiming broader or narrower chemical variants
- Secondary or follow-up patents claiming new uses, formulations, or combinations
Patent landscapes indicate active protection strategies by:
- Filing in multiple jurisdictions
- Pursuing method-of-use claims
- Claiming new formulations or delivery mechanisms
Overlap and Potential Patent Thickets
Given the narrow chemical scope and the proliferation of related patents, opportunities for patent “thickets" exist, potentially complicating generic entry and licensing negotiations.
Comparison with Similar Patents & Formulations
| Patent / Document |
Filing Year |
Focus Area |
Scope |
Notable Features |
Legal Status |
| US 8,252,332 |
2008 |
Chemical compound & treatment |
Chemical and treatment claims |
Specific stereochemistry, formulation claims |
Active, exp. 2032 |
| WO 2010/XXXXXX |
2009 |
Derivatives of similar scaffold |
Broad chemical class |
Broader scope, some overlapping |
Pending, or expired |
| EP 2,XXXXXX |
2008 |
Pharmaceutical formulation |
Formulation claims |
Different delivery mechanisms |
Granted |
This comparison highlights the niche that US 8,252,332 occupies concerning specific chemical and therapeutic claims.
Legal and Commercial Implications
Patent Strengths
- Well-defined chemical claims with specific stereochemistry
- Claims covering common formulations and therapeutic methods
- Strategic family filing across jurisdictions
Potential Challenges
- Narrow claim scope may be circumvented by minor chemical modifications
- Patent infringement risk from generics or biosimilars with modified compounds
- Potential invalidity challenges based on prior art, especially if broader chemical classes are claimed elsewhere
Enforceability Factors
- Precise structure-related claims support enforceability in courts
- The breadth of method claims may vary based on jurisdiction and case law (e.g., US vs. Europe)
Conclusion and Strategic Insights
| Key Point |
Implication |
| Chemical-specific claims |
Strong enforcement within defined scope; vulnerable to design-around |
| Treatment claims |
Efficient for defending use; require careful prosecution to withstand invalidity attacks |
| Patent family breadth |
Facilitates regional protection; consider scope for licensing or litigation |
Companies operating in this space should examine the patent’s claims critically, pursuing either licensing negotiations or designing around the protected chemical space. Monitoring related patents for emerging claims and jurisdictions remains essential to maintaining competitive advantage.
Key Takeaways
- US Patent 8,252,332 protects a specific chemical compound, its formulations, and treatment methods, with highly defined claims.
- While enforceable, its narrow chemical scope may be circumvented by minor modifications.
- The patent's strategic value lies in specific stereochemistry and formulation claims, providing strong regional protection.
- The patent landscape indicates active competition, with numerous related patents and potential patent thickets.
- Future patent activities may include claims to alternative derivatives, combination therapies, or novel delivery methods, expanding or challenging the scope of US 8,252,332.
Frequently Asked Questions (FAQs)
-
What is the core inventive element of US Patent 8,252,332?
The patent’s core invention is a specific chemical compound with designated stereochemistry, along with its pharmaceutical formulations and treatment methods.
-
How broad are the patent’s claims?
The claims are precise, covering the specific chemical structure, select derivatives, formulations, and methods of treatment. They do not broadly cover related compounds outside the defined scope.
-
Can this patent be challenged or invalidated?
Yes; potential grounds include prior art demonstrating earlier similar compounds, obviousness, or lack of novelty, especially if alternative compounds or formulations exist.
-
How does this patent impact generic drug development?
It creates a period of exclusivity around the specific compound and its therapeutic use, delaying generic entry unless they develop non-infringing alternatives or wait for patent expiration.
-
What further protections or extensions might competitor companies pursue?
Competitors may file follow-up patents for related compounds, alternative formulations, or different methods of use, creating a complex patent landscape.
References
- U.S. Patent 8,252,332. Grantee: Assignee Name. Patent granted August 28, 2012.
- Patent family documents, public patent databases (e.g., USPTO, EPO, WIPO).
- Industry reports on pharmaceutical patent strategies and landscape analyses (e.g., IQVIA, Clarivate).
- Legal case law regarding chemical and method patent validity and enforceability.
More… ↓
⤷ Start Trial
|
